We are live on ! Find out more
CT

Cambridge Trust Portfolio holdings

AUM $2.64B
1-Year Est. Return 28.73%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.1B
AUM Growth
-$138M
Cap. Flow
-$212M
Cap. Flow %
-10.1%
Top 10 Hldgs %
28.75%
Holding
831
New
19
Increased
68
Reduced
304
Closed
71

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$47.4M
2
UNP icon
Union Pacific
UNP
+$31.8M
3
UNH icon
UnitedHealth
UNH
+$21.1M
4
PXD
Pioneer Natural Resource Co.
PXD
+$12.8M
5
V icon
Visa
V
+$11.6M

Sector Composition

Rank Sector Weight
1 Technology 19.67%
2 Financials 14.51%
3 Healthcare 13.47%
4 Miscellaneous 13.36%
5 Consumer Discretionary 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPDW icon
576
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42B
$16.5K ﹤0.01%
513
GS icon
577
Goldman Sachs
GS
$301B
$16.4K ﹤0.01%
50
-208
-81% -$72.4K
ISRG icon
578
Intuitive Surgical
ISRG
$132B
$16.4K ﹤0.01%
64
BIO icon
579
Bio-Rad Laboratories Class A
BIO
$10.4B
$16.3K ﹤0.01%
34
-15
-31% -$7.02K
CNC icon
580
Centene
CNC
$32B
$16K ﹤0.01%
253
+155
+158% +$11K
CIEN icon
581
Ciena
CIEN
$53.6B
$15.8K ﹤0.01%
300
MDGL icon
582
Madrigal Pharmaceuticals
MDGL
$12.3B
$15.7K ﹤0.01%
65
IART icon
583
Integra LifeSciences
IART
$1.31B
$15.7K ﹤0.01%
274
-1,025
-79% -$57.8K
KIM icon
584
Kimco Realty
KIM
$16B
$15.4K ﹤0.01%
791
IAG icon
585
IAMGOLD
IAG
$11.8B
$15.4K ﹤0.01%
5,700
BUD icon
586
AB InBev
BUD
$158B
$15.4K ﹤0.01%
231
ABUS icon
587
Arbutus Biopharma
ABUS
$1B
$15.2K ﹤0.01%
5,000
RCI icon
588
Rogers Communications
RCI
$19.8B
$15.1K ﹤0.01%
325
EXC icon
589
Exelon
EXC
$45.3B
$14.9K ﹤0.01%
356
-154
-30% -$6.42K
VAW icon
590
Vanguard Materials ETF
VAW
$3.11B
$14.4K ﹤0.01%
81
SBIO icon
591
ALPS Medical Breakthroughs ETF
SBIO
$228M
$14K ﹤0.01%
516
-50
-9% -$1.51K
AEM icon
592
Agnico Eagle Mines
AEM
$104B
$14K ﹤0.01%
275
CELH icon
593
Celsius Holdings
CELH
$8.35B
$13.9K ﹤0.01%
450
HNI icon
594
HNI Corp
HNI
$3.55B
$13.9K ﹤0.01%
500
AZN icon
595
AstraZeneca
AZN
$252B
$13.9K ﹤0.01%
100
MBB icon
596
iShares MBS ETF
MBB
$39B
$13.7K ﹤0.01%
145
TFC icon
597
Truist Financial
TFC
$61.6B
$13.6K ﹤0.01%
400
+17
+4% +$742
FFIV icon
598
F5
FFIV
$22.3B
$13.5K ﹤0.01%
93
SNY icon
599
Sanofi
SNY
$107B
$13.5K ﹤0.01%
248
BDJ icon
600
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.75B
$13.2K ﹤0.01%
1,539

Similar funds

Cambridge Trust's Q1 2023 Portfolio in Review

As of Q1 2023, Cambridge Trust held 831 positions worth $2.1B, down 6.2% from $2.24B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Cambridge Trust withdrew a net $212M in Q1 2023, closing 71 positions and reducing 304 holdings. Its most notable exit was Linde, an estimated $47.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Cambridge Trust opened a new position in State Street SPDR S&P 600 Small Cap Value ETF worth $343K.

  • Cambridge Trust's largest Q1 2023 buy was State Street SPDR S&P 600 Small Cap Value ETF: 4,500 shares worth $343K.
  • Cambridge Trust added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2023, an estimated $5.28M increase.
  • Cambridge Trust's biggest Q1 2023 reduction was Union Pacific, cutting an estimated $31.8M.
  • Cambridge Trust fully exited Linde in Q1 2023, selling an estimated $47.4M.
  • Cambridge Trust's ten largest holdings make up 29% of its $2.1B portfolio in Q1 2023.
  • Cambridge Trust opened 19 new positions and closed 71 in Q1 2023.
  • Cambridge Trust's portfolio value fell 6.2% quarter-over-quarter to $2.1B.

Based on Cambridge Trust's 13F filing for Q1 2023, filed 12 May 2023.